OOIR: Observatory of International Research

Papers

(The TQCC of Pituitary is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	124
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies	52
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life	45
Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient survey	38
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening	36
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	35
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	32
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	32
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	31
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	30
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	29
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	27
Pituitary: hic manebimus optime	26
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly	24
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	24
Genetic models of Cushing’s disease	23
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	23
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	22
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	22
Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria	21
Pituitary metastases: a case series and scoping review	21
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	21
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	20
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	20
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	20

The efficacy of minimally invasive intraoperative ultrasound in endoscopic pituitary surgery	19
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	19
Machine learning as a clinical decision support tool for patients with acromegaly	19
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	18
Psychological profiles of patients with acromegaly: personality traits, quality of life, and clinical correlates	17
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy	17
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	17
IGF-1 is positively associated with BMI in patients with acromegaly	16
Commentary: The updated European society of endocrinology clinical practice guideline for the management of aggressive pituitary tumors and pituitary carcinomas	16
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	16
Diagnosis of growth hormone deficiency: searching for Consensus along life	16
Diagnostic performance of desmopressin stimulation test in pediatric cushing’s disease	15
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	15
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	15
TSH-secreting pituitary adenomas and bone	15
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	14
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	14
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	14
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	14
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)	14
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	13
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”	13
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	13
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	13
Outcomes in surgical management of microprolactinomas: an international multi-institutional series	13
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly	13
Cushing’s disease and bone	13
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study	13
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study	13
Acromegaly is associated with a distinct oral and gut microbiota	12
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade	12
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome	12
From misclassified AIP variant to carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predisposition	12
Pituitary surgery and COVID	12
Development and validation of clinical screening systems for Cushing disease in the United States	12
Circadian rhythm proteins as potential biomarkers in pituitary adenomas: an immunohistochemical analysis	12
Copeptin after pituitary surgery: is it worth measuring?	11
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience	11
Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study	11
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review	11
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort	11
Anemia in acromegaly: Prevalence, etiologies, and predictors from a large tertiary center cohort	11
Is diabetes with acromegaly for life?	11
Validation and modification of the PANOMEN 3 classification for predicting long-term recurrence/progression and quality of life in patients with pituitary adenomas: a multicentre retrospective cohort	11
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort	11
Long COVID and pituitary dysfunctions: a bidirectional relationship?	10
SAGIT®, ACRODAT®, PANOMEN 3… time to implement tools for management of acromegaly..?	10
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	10
Refractory nonfunctioning pituitary adenomas	10
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis	10

Serum IGF-1 May be less reliable when assessing the GH-IGF-1 axis in the elderly	10
Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly	10
Nelson’s syndrome: reappraisal of an uncommon disease	10
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis	10
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study	10
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas	10
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis	10
Characterization of a paradoxical post-operative increase in serum cortisol in Cushing disease	10
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults	10
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	10
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	9
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	9
Outcomes of stereotactic radiosurgery in nelson’s syndrome: a systematic review and Meta-Analysis	9
Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing’s disease	9
Skeletal fragility in pituitary disease: how can we predict fracture risk?	9
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	9
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	9
Cushing’s disease: role of preoperative and primary medical therapy	8
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	8
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	8
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	8
The effect of growth hormone replacement therapy on craniopharyngioma recurrence: a systematic review and meta-analysis	8
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	8
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	8
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	8
Alert: misinformation that may hurt patients with both adrenal insufficiency and AVP deficiency	8
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	8
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	8
The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?	8
Giant prolactinomas, a detailed analysis of 196 adult cases	7
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	7
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	7
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	7
An update on, and genetics of refractory adenomas of childhood	7
Correction: consensus on criteria for acromegaly diagnosis and remission	7
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	7
Surgical management in very elderly patients with pituitary adenoma: a multivariable assessment of the surveillance, epidemiology, and end results database	7
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	7
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	7
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	7
Cushing’s syndrome: Guidance on thromboprophylaxis at last	7